Series B startups in Jiangsu, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Renshuo Solar | Suzhou | Series B | $15.0M | 2026-10-22 |
| Juxie Intelligent | Wuxi Shi | Series B | $14.9M | 2026-09-28 |
| Xunjie Guangyuan | Wuxi Shi | Series B | $14.9M | 2026-09-28 |
| Yuce Biotechnology | Suzhou | Series B | $7.4M | 2026-08-31 |
| PMT Technologies | Suzhou | Series B | $14.8M | 2026-08-05 |
| HemaCell | Suzhou | Series B | $14.8M | 2026-06-02 |
| ChangingTek | Taicang | Series B | $14.5M | 2026-03-27 |
| AccuPulse | Suzhou | Series B | $14.5M | 2026-03-13 |
8 rows of the CSV in 5 of its 18 columns.
- The 343 series b startups in Jiangsu, China have raised $5.4B in total.
- 75 of them closed their most recent round in the last 12 months, $1.7B combined.
- The largest of those rounds is TV Joy's $294.8M Series B, dated July 2026.
- The most recent is Limiaoda Intelligent Technology's $74.9M Series B on 22 October 2026.
- Qiming Venture Partners is an investor in 5 of them, more than any other fund.
- Hardware is the most common sector, with 95 companies (28%).
- 20% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (27% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
25 of 343| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Renshuo Solar | Renshuo Solar manufactures perovskite tandem solar panels. | Energy | Suzhou | Series B | $15.0M | 2026-10-22 | $15.0M | Oriental Fortune Capital, K2VC, CAS Star +2 | 51 to 100 | 2021 |
| Juxie Intelligent | Juxie Intelligent develops and produces harmonic reducers. | Artificial intelligence | Wuxi Shi | Series B | $14.9M | 2026-09-28 | $28.9M | Nanjing Innovation Capital Group | 11 to 50 | 2019 |
| Xunjie Guangyuan | Xunjie Guangyuan develops near-infrared spectroscopy analysis instruments. | Artificial intelligence | Wuxi Shi | Series B | $14.9M | 2026-09-28 | $29.0M | Fortune Venture Capital, Genesis Capital, Xianting Fund | 51 to 100 | 2016 |
| Yuce Biotechnology | Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. | Biotech | Suzhou | Series B | $7.4M | 2026-08-31 | $22.4M | Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 | 101 to 250 | 2019 |
| PMT Technologies | PMT Technologies develops and manufactures measurement technology products. | Hardware | Suzhou | Series B | $14.8M | 2026-08-05 | $16.2M | CAS Star | 101 to 250 | 2019 |
| HemaCell | HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. | Biotech | Suzhou | Series B | $14.8M | 2026-06-02 | $62.0M | Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation | 1 to 10 | 2021 |
| ChangingTek | ChangingTek develops advanced robotics and artificial intelligence technology. | Artificial intelligence | Taicang | Series B | $14.5M | 2026-03-27 | $14.5M | CHENGMEI VENTURES, Aistar Ventures, Suzhou Agricultural Development Group | 11 to 50 | 2018 |
| AccuPulse | AccuPulse develops pulsed electric field ablation generators and catheters. | Health care | Suzhou | Series B | $14.5M | 2026-03-13 | $72.5M | BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 | 11 to 50 | 2020 |
| Tingsheng Technology | Tingsheng Technology develops intracardiac ultrasound (ICE) products. | Health care | Nanjing | Series B | $13.9M | 2026-03-05 | $52.8M | Qiming Venture Partners, Taiyu Investment, Tao Capital +2 | 2017 | |
| D3 Bio | D3 Bio develops and registers medicines as a biotechnology company. | Biotech | Wuxi Shi | Series B | $108.0M | 2025-12-09 | $370.0M | Matrix Partners China, Boyu Capital, Medicxi | 1 to 10 | 2020 |
| Skysys | Skysys provides data acquisition and analysis services for drones. | Artificial intelligence | Suzhou | Series B | $13.9M | 2025-06-23 | $39.3M | Oriza Holdings, Ivy Capital, CM Venture Capital | 11 to 50 | 2017 |
| Hope Medicine | Hope Medicine develops science-driven biopharmaceutical treatments in clinical development. | Health care | Nanjing | Series B | $18.5M | 2024-09-27 | $102.6M | Qiming Venture Partners, Sinovation Ventures, Trustbridge Partners +2 | 1 to 10 | 2018 |
| Tuge Medical Technology | Tuge Medical Technology develops and industrializes 4K endoscopic imaging equipment and digital operating rooms. | Health care | Nanjing | Series B | $27.7M | 2024-04-10 | $27.7M | LongRiver Investments | 101 to 250 | 2018 |
| CureGenetics | CureGenetics develops medicines and molecular diagnostics for cancers and genetic diseases. | Biotech | Suzhou | Series B | $9.0M | 2024-03-28 | Qiming Venture Partners, Oriza Holdings, Qingsong Fund +1 | 51 to 100 | 2016 | |
| VelinkTech | VelinkTech designs and develops high-speed transmission and communication chips for in-vehicle networks. | Hardware | Suzhou | Series B | $14.1M | 2024-01-02 | Summitview Capital, Tsinghua Research Capital, China Fortune-Innovation Capital | 2021 | ||
| Conowei New Energy Technology | Conowei New Energy Technology produces thermal management systems and their key components. | Energy | Wuxi Shi | Series B | $13.7M | 2023-11-10 | CDF-Capital, Xinshang Capital, Broad Vision Funds +1 | 11 to 50 | 2021 | |
| Onechip Bioelectronics | Onechip Bioelectronics develops biosensor chips and nanomaterials. | Biotech | Zhangjiagang | Series B | $13.7M | 2023-09-28 | Matrix Partners China, Qiming Venture Partners, Xiamen C&D Emerging Industry Equity Investment +1 | 11 to 50 | 2014 | |
| Huayita | Huayitai focuses on the semiconductor, panel, battery, and solar industries. | Energy | Nanjing | Series B | $13.7M | 2023-09-27 | Wuxi Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group, Hangyuan Fund +2 | 101 to 250 | 2020 | |
| Xilian Optical Core | Xilian Optical Core develops silicon photonics chip technology. | Hardware | Zhangjiagang | Series B | $13.7M | 2023-09-05 | China Merchants Venture Capital, Suzhou International Development Venture Capital, Summitview Capital +2 | 101 to 250 | 2020 | |
| Chamlion | Chamlion provides end-to-end digital dentistry solutions based on 3D printing. | Hardware | Nanjing | Series B | $34.3M | 2023-04-19 | Vertex Ventures China, Zhencheng Capital, 3H Health Investment +1 | 501 to 1,000 | 2017 | |
| Zhipu Technology | Zhipu Technology builds artificial intelligence spectrum analysis systems for military, environmental, agricultural, and medical uses. | Artificial intelligence | Nanjing | Series B | $14.5M | 2023-04-04 | Broad Vision Funds | 2018 | ||
| Weiyun AI | Weiyun AI combines medical health and artificial intelligence to manufacture clinical dental products. | Artificial intelligence | Nanjing | Series B | $15.2M | 2021-03-30 | AlphaX Partners | 1 to 10 | 2018 | |
| Meipian | Meipian provides a Chinese social media tool for authors and editors to create and beautify images and posts. | Software | Nanjing | Series B | $14.6M | 2018-08-08 | Matrix Partners China, ZhenFund, Dunhong Capital Management | 11 to 50 | 2015 | |
| Xiaoxiang Youpin | Xiaoxiang Youpin is an app that offers loan services. | Fintech | Wuxi Shi | Series B | $3.2M | 2018-01-30 | StarVC | 251 to 500 | 2016 | |
| Fclassroom | Fclassroom is an education firm powered by artificial intelligence. | Artificial intelligence | Wuxi Shi | Series B | $15.1M | 2017-10-31 | DHVC, XVC | 51 to 100 | 2014 |
Table 1. Series B startups in Jiangsu, China: the 25 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 343.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | D3 Bio | D3 Bio develops and registers medicines as a biotechnology company. | Biotech | Wuxi Shi | Series B | $108.0M | 2025-12-09 | $370.0M | Matrix Partners China, Boyu Capital, Medicxi | 1 to 10 | 2020 |
| 2 | Renshuo Solar | Renshuo Solar manufactures perovskite tandem solar panels. | Energy | Suzhou | Series B | $15.0M | 2026-10-22 | $15.0M | Oriental Fortune Capital, K2VC, CAS Star +2 | 51 to 100 | 2021 |
| 3 | Juxie Intelligent | Juxie Intelligent develops and produces harmonic reducers. | Artificial intelligence | Wuxi Shi | Series B | $14.9M | 2026-09-28 | $28.9M | Nanjing Innovation Capital Group | 11 to 50 | 2019 |
| 4 | Xunjie Guangyuan | Xunjie Guangyuan develops near-infrared spectroscopy analysis instruments. | Artificial intelligence | Wuxi Shi | Series B | $14.9M | 2026-09-28 | $29.0M | Fortune Venture Capital, Genesis Capital, Xianting Fund | 51 to 100 | 2016 |
| 5 | PMT Technologies | PMT Technologies develops and manufactures measurement technology products. | Hardware | Suzhou | Series B | $14.8M | 2026-08-05 | $16.2M | CAS Star | 101 to 250 | 2019 |
| 6 | HemaCell | HemaCell develops cell therapies that regenerate hematopoietic lineages in vitro through stem cell reprogramming. | Biotech | Suzhou | Series B | $14.8M | 2026-06-02 | $62.0M | Northern Light Venture Capital, CDH Investments, CMB International Capital Corporation | 1 to 10 | 2021 |
| 7 | AccuPulse | AccuPulse develops pulsed electric field ablation generators and catheters. | Health care | Suzhou | Series B | $14.5M | 2026-03-13 | $72.5M | BioVenture, Shanghai Biomedical Industrial Equity Investment Fund, Med-Fine Capital +1 | 11 to 50 | 2020 |
| 8 | ChangingTek | ChangingTek develops advanced robotics and artificial intelligence technology. | Artificial intelligence | Taicang | Series B | $14.5M | 2026-03-27 | $14.5M | CHENGMEI VENTURES, Aistar Ventures, Suzhou Agricultural Development Group | 11 to 50 | 2018 |
| 9 | Tingsheng Technology | Tingsheng Technology develops intracardiac ultrasound (ICE) products. | Health care | Nanjing | Series B | $13.9M | 2026-03-05 | $52.8M | Qiming Venture Partners, Taiyu Investment, Tao Capital +2 | 2017 | |
| 10 | Yuce Biotechnology | Yuce Biotechnology focuses on the industrialization of single-molecule immunodiagnostic technologies. | Biotech | Suzhou | Series B | $7.4M | 2026-08-31 | $22.4M | Puhua Capital, Zhengxuan Investment, BioTrack Capital +2 | 101 to 250 | 2019 |
Table 2. Series B startups in Jiangsu, China: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Qiming Venture Partners | Venture capital firm | Shanghai, China | 5 | 1% | 2 | Houmo.AI, Tingsheng Technology |
| 2 | Matrix Partners China | Venture capital firm | Beijing, China | 5 | 1% | 2 | Houmo.AI, D3 Bio |
| 3 | Oriza Holdings | Venture capital firm | Suzhou, China | 5 | 1% | 1 | Muchuang |
| 4 | Zhengxuan Investment | Venture capital firm | Shenzhen, China | 4 | 1% | 2 | Yuce Biotechnology, Bestar Coffee |
| 5 | Wuxi Capital | Angel group | Wuxi Shi, China | 4 | 1% | 1 | Muchuang |
| 6 | Suzhou International Development Venture Capital | Venture capital firm | Suzhou, China | 4 | 1% | 1 | Everlight Space |
| 7 | IDG Capital | Private equity firm | Beijing, China | 4 | 1% | ||
| 8 | CAS Star | Startup incubator | Xian, China | 3 | 1% | 2 | Renshuo Solar, PMT Technologies |
| 9 | Summitview Capital | Private equity firm | Beijing, China | 3 | 1% | 1 | Hepalink |
| 10 | Broad Vision Funds | Venture capital firm | Beijing, China | 3 | 1% | ||
| 11 | Vertex Ventures China | Venture capital firm | Beijing, China | 3 | 1% | ||
| 12 | K2VC | Angel group | Beijing, China | 2 | 1% | 1 | Renshuo Solar |
| 13 | SND Ventures Group | Private equity firm | Suzhou, China | 2 | 1% | 1 | Renshuo Solar |
| 14 | Nanjing Innovation Capital Group | Venture capital firm | Nanjing, China | 2 | 1% | 2 | Juxie Intelligent, Zhongzhiwei Technology |
| 15 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 2 | 1% | 1 | Xunjie Guangyuan |
Table 3. Series B startups in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Hardware | 95 | 28% | $1.7B |
| Health care | 85 | 25% | $2.3B |
| Software | 54 | 16% | $968.1M |
| Biotech | 46 | 13% | $1.6B |
| Energy | 32 | 9% | $237.2M |
| Artificial intelligence | 26 | 8% | $981.7M |
| Commerce | 24 | 7% | $102.4M |
| Education | 7 | 2% | |
| Fintech | 6 | 2% | $20.5M |
| Cybersecurity | 4 | 1% | $13.9M |
Table 4. Series B startups in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 343 | 100% | $14.1M |
Table 5. Series B startups in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Series B startups in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 1% | |
| October 2026 | 3 | 4% | $104.2M |
| September 2026 | 4 | 5% | $104.3M |
| August 2026 | 8 | 11% | $245.4M |
| July 2026 | 2 | 3% | $309.6M |
| June 2026 | 4 | 5% | $102.4M |
| May 2026 | 3 | 4% | $84.1M |
| April 2026 | 4 | 5% | $305.1M |
| March 2026 | 9 | 12% | $57.1M |
| February 2026 | 9 | 12% | $101.4M |
| January 2026 | 13 | 17% | $86.8M |
| December 2025 | 11 | 15% | $161.7M |
| November 2025 | 4 | 5% | $1.4M |
Table 7. Series B startups in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 60 | 17% | $1.5B |
| 2025 | 68 | 20% | $454.4M |
| 2024 | 24 | 7% | $309.1M |
| 2023 | 37 | 11% | $585.0M |
| 2022 | 28 | 8% | $899.1M |
| 2021 | 22 | 6% | $661.4M |
Table 8. Series B startups in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 2 | 1% |
| 2020 to 2022 | 64 | 19% |
| 2015 to 2019 | 142 | 42% |
| 2010 to 2014 | 92 | 27% |
| Before 2010 | 38 | 11% |
Table 9. Series B startups in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 32 | 11% |
| 11 to 50 | 77 | 27% |
| 51 to 100 | 62 | 22% |
| 101 to 250 | 60 | 21% |
| 251 to 500 | 27 | 10% |
| 501 to 1,000 | 16 | 6% |
| 1,001 to 5,000 | 8 | 3% |
| 10,001 or more | 1 | 0% |
Table 10. Series B startups in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when its most recent funding round is Series B and its headquarters is in Jiangsu, China. On 16 November 2026 that is 343 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 25 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 343 rows: 138 have no round amount, 0 no city and 148 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many series b startups in Jiangsu, China are on the list?
- 343, in the file dated 16 November 2026. 75 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 343 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.